- Price
- $270.22
- Day
- +1.10%
- Mkt Cap
- $651.20B
- 52W Range
- $173.33 – $281.07
- Volume
- 6.38M
- Beta
- 0.23
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Van Hulzen Asset Management LLC reduced its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 118,886 shares of the company's stock after selling 4,943 shares during the quarter. Johnson and
Read full article
Blue Edge Capital LLC reduced its stake in Johnson and Johnson (NYSE: JNJ) by 18.7% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,069 shares of the company's stock after selling 3,464 shares during the period. Blue Edge
Read full article
National Pension Service grew its holdings in Johnson and Johnson (NYSE: JNJ) by 1.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,226,968 shares of the company's stock after purchasing an additional 67,484 shares during the period. Johnson and Johnson comprises approximately
Read full article
Talon Private Wealth LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 89.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,588 shares of the company's stock after purchasing an additional 5,002 shares during
Read full article
Core Capital Management and Research inc. bought a new position in Johnson and Johnson (NYSE: JNJ) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,002 shares of the company's stock, valued at approximately $1,087,000. A number of other hedge
Read full article
U S Wealth Group LLC. raised its stake in Johnson and Johnson (NYSE: JNJ) by 15.1% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 17,259 shares of the company's stock after purchasing an additional 2,266 shares during the period. Johnson and Johnson accounts for approximately
Read full article
Retirees chasing a simple $500 monthly check from VYM run straight into a gap between how yields are calculated and how cash actually lands in your account, and the math gets uncomfortable fast.
Read full article
The Manufacturers Life Insurance Company lifted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 5.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,746,452 shares of the company's stock after purchasing an additional 180,724 shares during the
Read full article
Johnson & Johnson NYSE: JNJ Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its pharmaceutical pipeline, medical technology portfolio and capital flexibility.
Read full article
Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Read full article
In the most recent trading session, Johnson & Johnson (JNJ) closed at $270.22, indicating a +1.1% shift from the previous trading day.
Read full article
Johnson & Johnson has raised its dividend for 64 straight years, but faces billions in talc-related litigation liabilities. Kenvue offers a higher yield of 4.71%, but its pending acquisition by Kimberly-Clark creates uncertainty about its dividend outlook.
Read full article